Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice
- PMID: 23842497
- PMCID: PMC7094885
- DOI: 10.1038/nature12391
Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice
Abstract
On 29 March 2013, the Chinese Center for Disease Control and Prevention confirmed the first reported case of human infection with an avian influenza A(H7N9) virus. The recent human infections with H7N9 virus, totalling over 130 cases with 39 fatalities to date, have been characterized by severe pulmonary disease and acute respiratory distress syndrome (ARDS). This is concerning because H7 viruses have typically been associated with ocular disease in humans, rather than severe respiratory disease. This recent outbreak underscores the need to better understand the pathogenesis and transmission of these viruses in mammals. Here we assess the ability of A/Anhui/1/2013 and A/Shanghai/1/2013 (H7N9) viruses, isolated from fatal human cases, to cause disease in mice and ferrets and to transmit to naive animals. Both H7N9 viruses replicated to higher titre in human airway epithelial cells and in the respiratory tract of ferrets compared to a seasonal H3N2 virus. Moreover, the H7N9 viruses showed greater infectivity and lethality in mice compared to genetically related H7N9 and H9N2 viruses. The H7N9 viruses were readily transmitted to naive ferrets through direct contact but, unlike the seasonal H3N2 virus, did not transmit readily by respiratory droplets. The lack of efficient respiratory droplet transmission was corroborated by low receptor-binding specificity for human-like α2,6-linked sialosides. Our results indicate that H7N9 viruses have the capacity for efficient replication in mammals and human airway cells and highlight the need for continued public health surveillance of this emerging virus.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
Characterization of H7N9 influenza A viruses isolated from humans.Nature. 2013 Sep 26;501(7468):551-5. doi: 10.1038/nature12392. Epub 2013 Jul 10. Nature. 2013. PMID: 23842494 Free PMC article.
-
Limited airborne transmission of H7N9 influenza A virus between ferrets.Nature. 2013 Sep 26;501(7468):560-3. doi: 10.1038/nature12476. Epub 2013 Aug 7. Nature. 2013. PMID: 23925116 Free PMC article.
-
Mammalian Pathogenesis and Transmission of H7N9 Influenza Viruses from Three Waves, 2013-2015.J Virol. 2016 Apr 14;90(9):4647-4657. doi: 10.1128/JVI.00134-16. Print 2016 May. J Virol. 2016. PMID: 26912620 Free PMC article.
-
Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.J Virol. 2018 Jul 31;92(16):e00665-18. doi: 10.1128/JVI.00665-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29848587 Free PMC article.
-
Influenza Virus Infections in Polarized Cells.Viruses. 2022 Jun 15;14(6):1307. doi: 10.3390/v14061307. Viruses. 2022. PMID: 35746778 Free PMC article. Review.
Cited by
-
Pandemic preparedness through vaccine development for avian influenza viruses.Hum Vaccin Immunother. 2024 Dec 31;20(1):2347019. doi: 10.1080/21645515.2024.2347019. Epub 2024 May 28. Hum Vaccin Immunother. 2024. PMID: 38807261 Free PMC article. Review.
-
Amino acid 138 in the HA of a H3N2 subtype influenza A virus increases affinity for the lower respiratory tract and alveolar macrophages in pigs.PLoS Pathog. 2024 Feb 20;20(2):e1012026. doi: 10.1371/journal.ppat.1012026. eCollection 2024 Feb. PLoS Pathog. 2024. PMID: 38377132 Free PMC article.
-
Comparative Pathology of Animal Models for Influenza A Virus Infection.Pathogens. 2023 Dec 29;13(1):35. doi: 10.3390/pathogens13010035. Pathogens. 2023. PMID: 38251342 Free PMC article. Review.
-
A naturally occurring HA-stabilizing amino acid (HA1-Y17) in an A(H9N2) low-pathogenic influenza virus contributes to airborne transmission.mBio. 2024 Jan 16;15(1):e0295723. doi: 10.1128/mbio.02957-23. Epub 2023 Dec 19. mBio. 2024. PMID: 38112470 Free PMC article.
-
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults.Vaccine. 2024 Jan 12;42(2):295-309. doi: 10.1016/j.vaccine.2023.12.001. Epub 2023 Dec 16. Vaccine. 2024. PMID: 38105137 Clinical Trial.
References
-
- WHO. Avian influenza A(H7N9) virushttp://www.who.int/influenza/human_animal_interface/influenza_h7n9/en/in... (2013)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
